These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4480565)

  • 1. [Experimental basis of combination chemotherapy in the treatment of acute leukemia (author's transl)].
    Hoshino A
    Nihon Ketsueki Gakkai Zasshi; 1974 Oct; 37(5):731-9. PubMed ID: 4480565
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy in sequence for the treatment of L1210 leukemia.
    Roberts D; Hilliard SL
    Cancer Res; 1978 Aug; 38(8):2317-20. PubMed ID: 667827
    [No Abstract]   [Full Text] [Related]  

  • 3. [Strategy of antileukemic agents; the relationship between in vitro cell-killing kinetics and in vivo chemotherapeutic effects (author's transl)].
    Shimoyama M
    Nihon Ketsueki Gakkai Zasshi; 1974 Oct; 37(5):695-706. PubMed ID: 4480564
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined therapy of L1210 leukemia with Damvar and cytostatics.
    Pujman V; Cernochová S
    Neoplasma; 1979; 26(5):521-3. PubMed ID: 522924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [L 1210 leukemia, an experimental model for the potentiation of drugs used for acute leukemias].
    Pouillart P; Huong TH; Lhéritier J
    Bull Cancer; 1974; 61(4):509-26. PubMed ID: 4458834
    [No Abstract]   [Full Text] [Related]  

  • 6. Single versus combination chemotherapy of L1210 leukemia.
    Koza I; Balázová E; Ujházy V
    Neoplasma; 1980; 27(6):691-6. PubMed ID: 7254424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy: considerations for design and analysis.
    Lloyd HH
    Cancer Chemother Rep 2; 1974 Mar; 4(1):157-65. PubMed ID: 4826495
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental approach for the search of effective drug combination in cancer chemotherapy.
    Bello JL; Kariev NI; Mainardi JV; Betancourt M; Lage A; Barroso MC; Alfonso L
    Neoplasma; 1982; 29(1):65-71. PubMed ID: 7070556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone.
    Burns ER; Scheving LE
    Chronobiologia; 1980; 7(1):41-51. PubMed ID: 7438892
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.
    Gale GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
    Cancer Treat Rep; 1977; 61(3):445-50. PubMed ID: 872142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical designs for experiments in combination therapy.
    Miller I
    Cancer Chemother Rep 2; 1974 Mar; 4(1):151-6. PubMed ID: 4826494
    [No Abstract]   [Full Text] [Related]  

  • 12. An improved method for analyzing survival data from combination chemotherapy experiments.
    Carter WH; Stablein DM; Wampler GL
    Cancer Res; 1979 Sep; 39(9):3446-53. PubMed ID: 476674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).
    Woodman RJ
    Cancer Chemother Rep 2; 1974 Mar; 4(1):45-52. PubMed ID: 4826499
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental models and their clinical correlations.
    Carter SK; Goldin A
    Natl Cancer Inst Monogr; 1977 Mar; (45):63-74. PubMed ID: 927496
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cancerostatic effect of some fluorenone azomethines tested against leukemia L 1210 (author's transl)].
    Jungstand W; Gutsche W; Wohlrabe K; Schulze W
    Arch Geschwulstforsch; 1979; 49(1):15-7. PubMed ID: 444028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival analysis of drug combinations using a hazards model with time-dependent covariates.
    Stablein DM; Carter WH; Wampler GL
    Biometrics; 1980 Sep; 36(3):537-46. PubMed ID: 6783143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of leukemia L-1210 after treatment with the methionine synthetase inhibitor quinoline dibromide].
    Kudriavtsev IA; Paramonova TD; Golenko OD; Miasishcheva NV
    Probl Gematol Pereliv Krovi; 1982 Jul; 27(7):27-31. PubMed ID: 7122454
    [No Abstract]   [Full Text] [Related]  

  • 18. [Carminomycin in combination with some cytostatics. 1. Efficacy in leukemia L1210].
    Nowak C; Arnold W; Henneberger G; Tanneberger S
    Arch Geschwulstforsch; 1983; 53(1):45-52. PubMed ID: 6860085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
    Frei E; Schabel FM; Goldin A
    Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antitumor effect of compounds synthesized in the Division of Synthetic Chemistry (V) (author's transl)].
    Miyahara M; Kamiya S; Nakadate M; Sueyoshi S; Tanno M; Miyahara M
    Eisei Shikenjo Hokoku; 1981; 99():111-3. PubMed ID: 7332796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.